Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms
eLife · 24.01.2023 · 12
DOI: 10.7554/elife.69521 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 24.01.2023. Verfasst von Gary K L Chan und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, United Stat…. Hauptthemen laut MEDLINE: Cyclic AMP-Dependent Protein Kinases, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Genetic alterations that activate protein kinase A (PKA) are found in many tumor types. Yet, their downstream oncogenic signaling mechanisms are poorly understood. We used global phosphoproteomics and kinase activity profiling to map conserved signaling outputs driven by a range of genetic changes that activate PKA in human cancer. Two signaling networks were identified downstream of PKA: RAS/MAPK components and an Aurora Kinase A (AURKA)/glycogen synthase kinase (GSK3) sub-network with activity toward MYC oncoproteins. Findings were validated in two PKA-dependent cancer models: a novel, patient-derived fibrolamellar carcinoma (FLC) line that expresses a DNAJ-PKAc fusion and a PKA-addicted melanoma model with a mutant type I PKA regulatory subunit. We identify PKA signals that can influence both de novo translation and stability of the proto-oncogene c-MYC. However, the primary mechanism of PKA effects on MYC in our cell models was translation and could be blocked with the eIF4A inhibitor zotatifin. This compound dramatically reduced c-MYC expression and inhibited FLC cell line growth in vitro. Thus, targeting PKA effects on translation is a potential treatment strategy for FLC and other PKA-driven cancers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, United States.
- Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, United States.
- Department of Medicine, Harvard Medical School, Boston, United States.
- Massachusetts General Hospital Cancer Center, Boston, United States.
- Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, United States.
- J. David Gladstone Institute, San Francisco, United States.
ORCID-Profile: Gary K L Chan, Danielle L Swaney, John D Scott, John D Gordan
Förderung
- NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- Fibrolamellar Cancer Foundation
- Burroughs Wellcome Fund Career Award
- National Institutes of Health
- DOD Peer Reviewed Cancer Research Program
Zitieren
APA
Chan, G. K. L., Maisel, S., Hwang, Y. C., Pascual, B. C., Wolber, R. R. B., Vu, P., Patra, K. C., Bouhaddou, M., Kenerson, H. L., Lim, H. C., Long, D., Yeung, R. S., Sethupathy, P., Swaney, D. L., Krogan, N. J., Turnham, R. E., Riehle, K. J., Scott, J. D., Bardeesy, N., & Gordan, J. D. (2023). Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms. eLife, 12. https://doi.org/10.7554/elife.69521
Vancouver
Chan GKL, Maisel S, Hwang YC, Pascual BC, Wolber RRB, Vu P, et al. Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms. eLife. 2023;12. doi:10.7554/elife.69521
BibTeX
@article{Chan2023,
author = {Chan, Gary K L and Maisel, Samantha and Hwang, Yeonjoo C and Pascual, Bryan C and Wolber, Rebecca R B and Vu, Phuong and Patra, Krushna C and Bouhaddou, Mehdi and Kenerson, Heidi L and Lim, Huat C and Long, Donald and Yeung, Raymond S and Sethupathy, Praveen and Swaney, Danielle L and Krogan, Nevan J and Turnham, Rigney E and Riehle, Kimberly J and Scott, John D and Bardeesy, Nabeel and Gordan, John D},
title = {Oncogenic PKA signaling increases c-MYC protein expression through multiple targetable mechanisms},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.69521}
}
EUVIMED